David C. Blakey
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 9
- Glycosylation and Glycoproteins Research 3
- Oncology 14
- HER2/EGFR in Cancer Research 4
- Co-authors
- Simon T. Barry (4 shared papers)William C. Zamboni (1 shared paper)Omid C. Farokhzad (1 shared paper)Hiroshi Maeda (1 shared paper)Piotr Grodzinski (1 shared paper)Eva M. Sevick‐Muraca (1 shared paper)Uma Prabhakar (1 shared paper)Alberto Gabizón (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)Cancer Research (3 papers)Molecular Therapy (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Neoplasia (2 papers)
- Partner nations
- United KingdomUnited StatesTaiwan
In The Last Decade
David C. Blakey
50 papers receiving 3.5k citations
David C. Blakey's Hit Papers
Peers
Comparison fields: 5 of 108
- Biomaterials 749
- Cancer Research 504
- Biotechnology 276
- Molecular Biology 1.8k
- Immunology 518
Countries citing papers authored by David C. Blakey
This map shows the geographic impact of David C. Blakey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Blakey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Blakey more than expected).
Fields of papers citing papers by David C. Blakey
This network shows the impact of papers produced by David C. Blakey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Blakey. The network helps show where David C. Blakey may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Blakey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology Hit paper breakdown → | 2013 | 1207 |
| 2 | Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug Hit paper breakdown → | 2020 | 259 |
| 3 | ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. | 2002 | 200 |
| 4 | New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. | 1987 | 178 |
| 5 | Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. | 2002 | 147 |
| 6 | 2017 | 143 | |
| 7 | 2004 | 136 | |
| 8 | 2010 | 115 | |
| 9 | The first international conference on vascular targeting: meeting overview. | 2003 | 112 |
| 10 | Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody. | 1987 | 107 |
| 11 | 2011 | 105 | |
| 12 | 2017 | 91 | |
| 13 | 2011 | 89 | |
| 14 | 2018 | 73 | |
| 15 | Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. | 2002 | 72 |
| 16 | 2002 | 52 | |
| 17 | 2012 | 47 | |
| 18 | 1986 | 33 | |
| 19 | 2004 | 32 | |
| 20 | 1988 | 32 |
About David C. Blakey
David C. Blakey is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Cancer Research, having authored 52 papers that have together received 3.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Angiogenesis and VEGF in Cancer (9 papers), Toxin Mechanisms and Immunotoxins (7 papers), Transgenic Plants and Applications (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), HER2/EGFR in Cancer Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Biomaterials (749 citations), Cancer Research (504 citations), Biotechnology (276 citations), Molecular Biology (1.8k citations) and Immunology (518 citations). David C. Blakey has collaborated with scholars based in United Kingdom, United States and Taiwan. Frequent co-authors include Simon T. Barry, William C. Zamboni, Omid C. Farokhzad, Hiroshi Maeda, Piotr Grodzinski, Eva M. Sevick‐Muraca, Uma Prabhakar, Alberto Gabizón, Philip E. Thorpe and Nagy Habib. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Molecular Therapy, International Journal of Radiation Oncology*Biology*Physics and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.